Personalized Breast and Lung Cancer Care

“Personalized Breast and Lung Cancer Care” offers examination of the evolving landscape of cancer treatment, focusing on the intersection of molecular diagnostics, precision medicine, and holistic patient care.

Participants will gain insights into the epidemiological impact of lung cancer, with a focus on early detection and standard NSCLC treatment. The course also explores future perspectives in lung cancer surgery research, emphasizing advancements in segmentectomy procedures and the role of randomized controlled trials. Additionally, there is an advocacy for investment in innovative technologies, and the development of young talent in lung cancer surgical research, with a specific focus on understanding the heterogeneity of NSCLC and the importance of actionable biomarkers in treatment decisions.

In breast cancer management, the course emphasizes the role of molecular diagnostics and personalized treatment strategies. Participants will delve into Next-Generation Sequencing (NGS) technology, tumor gene-expression signatures, and predictive markers, gaining a comprehensive understanding of tailored therapies for breast cancer.

Throughout the program, emphasis is placed on the transformative potential of personalized oncology and cancer diagnostics in driving medical innovation. Participants engage with emerging therapies, precision radiotherapies, and the integration of Artificial Intelligence, fostering a nuanced understanding of the evolving landscape of cancer care.

By fostering dialogue and collaboration among healthcare professionals, researchers, and students, “Personalized Breast and Lung Cancer Care” aims to catalyze advancements in cancer treatment, ultimately improving patient outcomes and quality of life.